1. Dr. Hans-Joachim Schmoll. Colorectal cancer expert. Biography. 0
Dr. Hans-Joachim Schmoll, MD, explains his extensive career and contributions to cancer medicine. He is a professor and director of clinical oncology research in Germany....
▶⏸
2. Colon cancer screening. Which test is most effective? Part 1 of 2. Colonoscopy. 1-1
Dr. Hans-Joachim Schmoll, MD, explains how colon cancer screening saves lives. He details the effectiveness of colonoscopy for early detection.
▶⏸
3. Staging of colorectal cancer. Molecular cancer classification for precision treatment of tumors. 2-1
Dr. Hans-Joachim Schmoll, MD, explains how molecular classification is transforming colon cancer treatment. He details the limitations of current staging systems for stage II and...
▶⏸
4. Colorectal cancer stem cells. Immunotherapy of colon cancer. 3-1
Dr. Hans-Joachim Schmoll, MD, explains the critical role of cancer stem cells in treatment resistance and metastasis. He details how these cells evade chemotherapy and...
Dr. Hans-Joachim Schmoll, MD, explains how to use mutations in EGFR, BRAF, and MEK pathways to select a personalized treatment plan. He details the efficacy...
▶⏸
6. Colorectal cancer prognosis. Adaptive clinical trials. Prediction of response to treatment. 8-1
Dr. Hans-Joachim Schmoll, MD, explains how precision medicine and molecular tumor profiling are reshaping colon cancer prognosis. He details the shift from traditional staging to...
▶⏸
7. Quality of treatment of colorectal cancer varies greatly. 9-1
Dr. Hans-Joachim Schmoll, MD, explains how treatment quality varies globally. He details the critical role of multidisciplinary teams in creating optimal treatment plans.
▶⏸
8. Colon cancer screening. Which test is most effective? Tumor DNA tests from feces and blood. Part 2 of 2. 1-2
Dr. Hans-Joachim Schmoll, MD, explains how traditional fecal occult blood tests only detect intermediate or advanced stage cancers. He details the evolution to more sensitive...
▶⏸
9. Precision treatment of colon cancer. Patient’s genetic profile is important. 2-2
Dr. Hans-Joachim Schmoll, MD, explains how a patient's own genetic profile is critical for treatment personalization. He details recent clinical trial data showing germline mutations...
▶⏸
10. Colorectal cancer immunotherapy. Which patients benefit most? 3-2
Dr. Hans-Joachim Schmoll, MD, explains how immunotherapy activates the body's immune system to attack tumors. He details that immune checkpoint inhibitors are highly effective for...
▶⏸
11. Treatment of colorectal cancer with HER2 inhibitors. Herceptin and Lapatinib (Tykerb). 4-2
Dr. Hans-Joachim Schmoll, MD, explains HER2 inhibitors for colon cancer treatment. He details how trastuzumab (Herceptin) and lapatinib (Tykerb) target HER2-positive tumors. This dual inhibition...
Dr. Hans-Joachim Schmoll, MD, explains how the DPD enzyme predicts treatment response. DPD gene expression in a colon cancer tumor is a strong biomarker for...
▶⏸
13. Liquid biopsy in colorectal cancer. Precision diagnosis and treatment. 8-2
Dr. Hans-Joachim Schmoll, MD, explains how liquid biopsy transforms cancer monitoring. This advanced technique analyzes tumor DNA and RNA from a simple blood draw. It...
▶⏸
14. Every cancer patient must be evaluated by Tumor Board. Multidisciplinary Team. 9-2
Dr. Hans-Joachim Schmoll, MD, explains the critical importance of a Multidisciplinary Team (MD T) or Tumor Board for every cancer patient. He details how this...
▶⏸
15. Stage 3 colon cancer treatment. Capecitabine (Xeloda) and 5-Fluorouracil (5-FU). 5-1
Dr. Hans-Joachim Schmoll, MD, explains stage 3 colon cancer therapy. He details the critical role of optimal surgery and lymph node removal.
▶⏸
16. Chemotherapy of rectal cancer. Capecitabine (Xeloda) and oxaliplatin 5-FU. Controversies. 5-3
Dr. Hans-Joachim Schmoll, MD, explains the role of chemotherapy in rectal cancer treatment. He details how chemotherapy and radiotherapy can sometimes eradicate tumors before surgery....
Dr. Hans-Joachim Schmoll, MD, explains advanced treatment options for stage 4 colon cancer with liver or lung metastases. He details how systemic chemotherapy can convert...
▶⏸
18. Colorectal cancer chemotherapy in elderly. Choose treatment based on fitness. 6
Dr. Hans-Joachim Schmoll, MD, explains how to choose chemotherapy for elderly patients. Over half of colorectal cancer cases are diagnosed in patients over 70. Treatment...
▶⏸
19. Rectal cancer therapy without surgery. Future of Colorectal cancer treatment. 10
Dr. Hans-Joachim Schmoll, MD, explains how rectal cancer treatment is evolving. Chemotherapy and radiation can sometimes eradicate rectal tumors completely. This allows select patients to...
Refine your treatment plan with a panel of top doctors who precisely fit your case.
